1. Effect of weekly versus daily primaquine on Plasmodium vivax malaria recurrences: A real-life cohort study.
- Author
-
Brito-Sousa JD, Phanor J, Balieiro PCDS, Silva-Neto AV, Cordeiro JSM, Vitor-Silva S, Mendes M, Sampaio VS, Melo GC, Lacerda M, and Monteiro W
- Subjects
- Cohort Studies, Humans, Primaquine therapeutic use, Recurrence, Antimalarials therapeutic use, Malaria, Vivax drug therapy
- Abstract
Background: Although primaquine (PQ) is indicated for G6PD-deficient patients, data on weekly PQ use in Brazil are limited., Methods: We aimed to investigate malaria recurrences among participants receiving daily and weekly PQ treatments in a real-life setting of two municipalities in the Amazon between 2019 and 2020., Results: Patients receiving weekly PQ treatment had a lower risk of recurrence than those receiving daily PQ treatment (risk ratio: 0.62, 95% confidence interval: 0.41-0.94), using a model adjusted for study site., Conclusions: Weekly PQ use did not increase the risk of malaria recurrence. Further studies with larger populations are warranted.
- Published
- 2022
- Full Text
- View/download PDF